| # | Security | Value | Shares | % Port | Change | Δ Shares |
|---|---|---|---|---|---|---|
| 1 | CME GROUP INC COM | $1.0B | 3.48M | 25.6% | NEW | — |
| 2 | PLANET LABS PBC COM CL A | $985.2M | 35.25M | 24.5% | ADDED | +3.31M |
| 3 | AST SPACEMOBILE INC COM CL A | $741.1M | 8.94M | 18.5% | —HELD | 0 |
| 4 | REVOLUTION MEDICINES INC COM | $320.2M | 3.29M | 8.0% | ADDED | +3.24M |
| 5 | ARM HOLDINGS PLC SPONSORED ADS | $296.6M | 1.96M | 7.4% | —HELD | 0 |
| 6 | FRESHWORKS INC CLASS A COM | $115.0M | 14.33M | 2.9% | —HELD | 0 |
| 7 | UIPATH INC CL A | $78.1M | 7.03M | 1.9% | —HELD | 0 |
| 8 | TEMPUS AI INC CL A | $70.1M | 1.55M | 1.7% | —HELD | 0 |
| 9 | PAYPAY CORP SPONSORED ADS | $66.7M | 3.13M | 1.7% | NEW | — |
| 10 | GITLAB INC CLASS A COM | $59.0M | 2.72M | 1.5% | —HELD | 0 |
| 11 | PRIME MEDICINE INC COM | $57.6M | 16.56M | 1.4% | —HELD | 0 |
| 12 | ETHOS TECHNOLOGIES INC CL A | $42.1M | 3.77M | 1.0% | NEW | — |
| 13 | MAZE THERAPEUTICS INC COM | $41.4M | 1.39M | 1.0% | —HELD | 0 |
| 14 | BRIDGEBIO ONCOLOGY THERAPEUT COM NEW | $25.3M | 2.82M | 0.6% | —HELD | 0 |
| 15 | RELAY THERAPEUTICS INC COM | $15.6M | 1.56M | 0.4% | ADDED | +1.56M |
| 16 | FRESHWORKS INC CLASS A COM | $15.1M | 1.88M | 0.4% | REDUCED | -12,447,903 |
| 17 | MONTE ROSA THERAPEUTICS INC COM | $11.3M | 684.3K | 0.3% | REDUCED | -60,673 |
| 18 | VERA THERAPEUTICS INC CL A | $9.7M | 241.3K | 0.2% | —HELD | 0 |
| 19 | SANA BIOTECHNOLOGY INC COM | $8.1M | 2.81M | 0.2% | —HELD | 0 |
| 20 | BEAM THERAPEUTICS INC COM | $7.7M | 321.6K | 0.2% | —HELD | 0 |
| 21 | LYELL IMMUNOPHARMA INC COM NEW | $5.9M | 293.3K | 0.1% | —HELD | 0 |
| 22 | OSCAR HEALTH INC CL A | $5.5M | 482.0K | 0.1% | —HELD | 0 |
| 23 | FIGMA INC CLASS A COM STK | $4.6M | 215.6K | 0.1% | —HELD | 0 |
| 24 | SPERO THERAPEUTICS INC COM | $2.1M | 890.0K | 0.1% | —HELD | 0 |
| 25 | HYPERFINE INC COM CL A | $971K | 898.7K | 0.0% | —HELD | 0 |
Holdings data sourced from SEC EDGAR 13F-HR filings. Updated quarterly, approximately 45 days after quarter end. All data is public domain.
Last filed: May 8, 2026